- Report
- May 2026
- 476 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 375 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 464 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 478 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 192 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 82 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 376 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 286 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 186 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 285 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 280 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 368 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 451 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 280 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- January 2026
- 182 Pages
Global
From €3995EUR$4,500USD£3,461GBP
- Report
- May 2026
- 271 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 381 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 272 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 193 Pages
Global
From €5193EUR$5,850USD£4,500GBP
- Report
- May 2026
- 144 Pages
Global
From €5193EUR$5,850USD£4,500GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more